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Abstract. Medical guidelines and protocols are documents aimed
at improving the quality of medical care by offering support in medi-
cal decision making in the form of management recommendations
based on scientific evidence. Whereas medical guidelines are in-
tended for nation-wide use, and thus omit medical management de-
tails that may differ among hospitals, medical protocols are aimed
at local use within hospitals and, therefore, include detailed infor-
mation. Although a medical guideline and protocol concerning the
management of a particular disorder are related to each other, one
question is to what extent they are different. Formal methods are ap-
plied to shed light on this issue. A Dutch medical guideline regarding
the treatment of breast cancer, and a Dutch protocol based on it, are
taken as an example.
1 Introduction
Medical management is increasingly based on recommendations
from the medical scientific community, summarised in medical
guidelines and protocols. Medical guidelines are systematically de-
veloped, structured documents, containing conclusions and recom-
mendations, based on scientific evidence [7]. These documents are,
therefore, called evidence-based guidelines. Medical protocols are
local adaptations of medical guidelines.
The goal of the work described here was to better understand
the differences and similarities between guidelines and protocols. A
start of obtaining insight into these issues is yielded by an informal
analysis, where the structure and content of a medical guideline and
protocol concerning the medical management of one particular dis-
order, here breast cancer, are studied. Based on the results of this
analysis, we have carried out a formal analysis of parts of both the
guideline and protocol of breast cancer treatment. This is done by
looking at both medical protocols and guidelines as defining (logi-
cal) constraints on the medical management of patients performed
in practice. This approach was inspired by a statement by Wiersma
and Burgers that “recommendations in guidelines should not only be
based on evidence extracted from scientific literature, but take into
account the context of daily medical practice as well”.3 In principle
this approach would allow one to discover flaws or suboptimal man-
agement actions in the medical management in practice, assuming
that a given protocol and guideline are correct, or to find incorrect
or suboptimal medical management decisions in a protocol or guide-
line, assuming that the medical management in practice is correct
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and optimal. In the research described in this document we investi-
gate whether this is really possible using a combination of informal
and formal, in particular model checking, methods.
2 Medical Guidelines and Protocols
A medical guideline is an extensive document, developed by a work-
ing group of professionals involved in the management of the disor-
der covered by the guideline. By definition, a protocol is seen as a
local version of a guideline, meant to be useful as a guide for daily
clinical care. The need for a protocol in conjunction with a guide-
line is twofold: firstly, a guideline is an extensive document (e.g., the
breast-cancer guideline is 121 pages in A4 format), and, therefore,
it is not easy to locate relevant information; secondly, detailed rec-
ommendations about duration, dose, or actual procedure have been
omitted from the guideline, and, thus, are added in a protocol to com-
plement the information that is in the guideline. Hence, basically, a
medical protocol is a summary of the most important sections that
are in the guideline, mostly recommendations, supplemented with
hospital-specific details concerning the treatment. This implies that
many sections in a protocol may be very similar to related sections
in a guideline. However, there may also be differences, partly due to
differences in opinion between the guideline designers and protocol
designers, and partly due to the difference in purpose of a guideline
and protocol. The guideline that we have used in this study was the
2004 version of the Dutch CBO guideline on the treatment of breast
cancer. The protocol that we have used was the protocol of the Dutch
Integral Cancer Centre East (IKO in Dutch), which was based on the
CBO guideline; the principal protocol developer was fully aware of
the context of the breast cancer guideline and was later included in
the guideline development team. As a consequence, much of what is
included in the guideline is also in the protocol.
To understand the differences between breast cancer treatment in
the guideline and the protocol, we present a number of examples
where the recommendations of the guideline and protocol differs.
1. In the IKO protocol, an ultrasound axilla is suggested as default
during the sentinel node procedure to asses the stage of the dis-
ease. CBO does not provide such a default.
2. IKO recommends first radiotherapy, then chemotherapy; CBO
specifically does not recommend any order.
3. In case of isolated tumour cells, sentinel node dissection can be
omitted according the CBO guideline, in contrast to the IKO pro-
tocol where additional axillary treatment is recommended in any
case.
The first difference is due to the fact that the protocol is more specific
than the guideline. Such a difference is also referred to as ‘cookbook’
difference indicating that the difference is no more than an insignifi-
cant refinement compared to the guideline. The second difference is
also a ‘cookbook’ difference and is due to agreements with other re-
gional hospitals. The guideline does not recommend any order and as
a consequence, the hospitals may choose a specific order to gain, for
example, efficiency. The third difference is not a cookbook difference
as it is a significant change in advise and, assuming a closed world
assumption on the interventions that may be performed, can be seen
as a contradiction. However, the evidence underlying the guideline
advice was based on retrospective studies and is therefore uncertain.
There are some important observations that can be made on the
basis of a more elaborate analysis that was performed. First, there
are few real differences (i.e., differences that cannot be described in
terms of a refinement) between the protocol and the guideline: most
of them are ‘cookbook differences’. The main reason for this is that
this particular protocol is heavily based on the guideline and the writ-
ers are involved in both the guideline and the protocol. As a conse-
quence, the evidence used is the same in both cases, and therefore
the recommendations are very similar. Second, considering the level
of evidence of studies supporting the differences, it was found that
almost all differences are related to guideline pieces with a low level
of evidence (level C/grade 4). In our findings, there was only one
such case, which could be justified on the basis that strong evidence
mentioned in the guideline was superseded by new evidence.
3 Medical Management in Breast Cancer
First, we give an informal description on the medical management
as stated in the CBO guideline (and IKO protocol) that deals with
locoregional treatment of operable breast cancer, i.e., T1-2 N0-1 M0
breast cancer according to the TNM classification system [9]. There-
after, we discuss temporal logic as a means for formalizing the med-
ical management of breast cancer.
3.1 Informal Description of Medical Management
According to the CBO guideline there are only two options for local
treatment of operable invasive breast cancer: breast-conserving ther-
apy (BCT) or modified radical mastectomy (MRM). BCT implies
ample local excision of the tumour, an axillary staging procedure,
and radiotherapy of the breast. MRM involves a total resection of the
breast (mastectomy) and dissection of the axillary nodes (AD). The
aim of BCT is to achieve a survival rate comparable to that following
MRM with an optimal cosmetic result in terms of the treated breast.
BCT is usually the preferred treatment unless the patient has a clear
preference for MRM and there are no contra indications for BCT,
i.e., there is no
- multicentricity (two or more tumour foci in different quadrants),
- diffuse malignant microcalcifications, or
- previous radiotherapy of the breast.
Another contra indication for BCT is obtained during surgery:
- the margins of the local excision remain tumour-positive after re-
peated local excision attempts.
In this case, local excision attempts are unsuccessful in removing the
primary tumour and treatment therefore switches to MRM.
Treatment of the axillary nodes is also part of the treatment of
breast cancer as the pathologic assessment of axillary lymph nodes
remains the most important prognostic variable for the invasive
breast cancer patient. An optimal assessment would be achievable by
means of a complete axillary node dissection (AND). However, AND
may lead to morbidity, e.g., pain, limited shoulder movement. An al-
ternative for axillary staging is the sentinel node procedure (SNP),
which only dissects the sentinel nodes, i.e., those nodes that drain
the area of the breast where the primary tumour is located and thus
are most likely to contain metastasis. The SNP is currently the stan-
dard procedure for axillary staging in breast cancer provided that the
contra-indications do not hold, where contra-indications of SNP are
defined as
- suspected or proven malignancy in the axillary nodes,
- tumour > T2,
- multiple tumour foci, and
- potentially disrupted lymph drainage due to recent axillary surgery
or a large biopsy cavity following tumour excision.
When the SNP is not possible, complete axillary node dissection
should be carried out. Furthermore, treatment of the axilla is in-
dicated (i.e., dissection, radiotherapy) for all forms of lymph node
metastasis.4
3.2 Temporal Logic Representation
The CBO guideline can be interpreted as (temporal) constraints on
medical management. It has been shown in [12] that the step-wise,
possibly iterative, execution of a guideline can be described precisely
by means of temporal logic. The logic that we use here for specifying
properties of medical guidelines is a combination of Computation
Tree Logic (CTL) [3, 4, 6] and Linear Temporal Logic (LTL) [14].
CTL uses atomic propositions and Boolean connectives (e.g.,
¬,∨,∧) to build up more complicated expressions for describing
properties of states. Furthermore, CTL formulas can be composed
of path quantiers and temporal operators for describing properties
of computation trees, i.e., all paths that are possible from a certain
state. The path quantifiers are A and E to specify that all of the paths
or some of the paths starting at a specific state have some property.
The temporal operators describe properties of a path through the tree.
The four temporal operators used are X, G, F, and U. With Xϕ being
true if ϕ holds in the next state, Gϕ if ϕ holds in the current state
and all future states, Fϕ if ϕ holds in some state in the future (or is
true in the current state), ϕUψ if ϕ holds until ψ holds, i.e., there is a
state on the path where ψ holds and in every preceding state ϕ holds.
LTL provides operators for describing events along a single com-
putation path. Each formula is of the form Af , with f being a path
formula, which is either an atomic proposition or inductively defined
as ¬f , f ∨ g, f ∧ g, Xf , Ff , Gf , or fRg with f, g path formulas.
The language we use for atomic propositions consists of medical
actions Actions, medical plans Plans, and data structures Data:
Actions : {tumour-excision,mastectomy, axilla-dissection,
sentinel-node}
Plans : {TREATMENT,BCT,MRM,AXILLA-STAGING}
Data : {CI-BCT, CI-SN, TF, SN, ITC}
with CI-BCT, CI-SN ∈ {>,⊥} denoting the contra indications for
BCT and SN respectively, SN ∈ {unknown, neg, pos} denotes
whether there is a metastasis found in the lymph nodes after perform-
ing the SN procedure, TF ∈ {unknown,>,⊥} denotes whether
the re-section margins are tumour free, and ITC ∈ {>,⊥} denotes
whether there are isolated tumour cells.
4 The CBO guideline differs at this point with the IKO protocol as it makes
an exception for isolated tumour cells.
4 Formalisation of Medical Management
Here, we give a constrained-based representation of the CBO guide-
line using the temporal logic representation discussed in the previous
section. Furthermore, we interpret the recommendations in the IKO
protocol and represent this in a more or less executable model. The
goal is to verify whether the model of the protocol complies with the
recommendations of the CBO guideline, or if there are differences,
using a model checking approach [5].
4.1 Constrained-Based Represention Guideline
The final representation in temporal logic of the medical manage-
ment in the CBO guideline is shown in Figure 1.
Constraints related to control structure
(1) AG(TREATMENT → AF(BCT ∨ MRM))
(2) AG(CI-BCT → ¬BCT)
(3) AG(BCT → AF(AXILLA-STAGING ∨ MRM)∧
AF tumour-excision)
(4) AG(MRM → AF axilla-dissection ∧ AF mastectomy)
(5) AG(AXILLA-STAGING →
AF (axilla-dissection ∨ sentinel-node))
(6) AG(CI-SN → ¬sentinel-node)
(7) AG(tumour-excision →
((TF = ⊥ → AF MRM) ∧ (TF = > → AG ¬MRM))
(8) AG(sentinel-node →
(SN = pos ∧ ¬ITC → AF axilla-dissection))
(9) (G¬MRM) → AG(sentinel-node →
AG(ITC → AG¬axilla-dissection))
(10) AG(TREATMENT → (CI-SN → AF axilla-dissection))
Constraints related to data
(11) (CI-BCT → AG CI-BCT) ∧ (¬CI-BCT → AG ¬CI-BCT)
(12) (CI-SN → AG CI-SN) ∧ (¬CI-SN → AG ¬CI-SN)
Figure 1. Constraint-based representation of the CBO guideline. BCT =
breast conserving treatment, MRM = modified radical mastectomy, CI-BCT
= contra indications for BCT, SN = result of sentinel node procedure, CI-SN
= contra indications for SN, tumour-excision = segmental tumour excision,
TF = tumour free resection margins.
Some constraints given by the guideline are not easily express-
ible in temporal logic, as they are not one to one related to the order
of the protocol but involve other modalities except for time, such as
the preference for BCT over MRM and the preference for the SNP
over axilla-dissection for staging the axilla. Other assumptions re-
garding the patient data are implicit in the guideline, e.g., the status
of the resection margins, i.e., whether they are tumour free (TF) or
not (¬TF), only becomes known after excision of the tumour and the
existence of metastasis (SN=pos or SN=neg) only becomes known af-
ter the SNP. Here we have chosen not to consider these more implicit
constraints.
4.2 Asbru Representation of the IKO Protocol
Much research has already been devoted to the development of rep-
resentation languages for medical guidelines. Most of them consider
guidelines as a composition of actions, controlled by conditions.
However, many languages are not formal enough for the purpose
of our research as they often incorporate free-text elements which
do not have a clear semantics. Exceptions to this are PROforma [8]
and Asbru [16]. Here we use Asbru, because in previous research its
semantics has been defined precisely [1] and can be translated auto-
matically into SMV for model checking purposes [2].5
The overall structure of the Asbru model is given in Figure 2. It
consists of nine plans ordered in a hierarchy. The top level plan ‘treat-
ment’ will start by selecting the BCT plan, which may be rejected
in case there are contra indications against doing breast conserving
therapy. In that case, treatment will continue with a modified radi-
cal mastectomy (MRM). In case BCT is successfully completed, the
treatment also completes and the MRM plan will not be started. The
‘BCT surgery’ plan consists of axillary staging and tumour excision,
which are modelled as unordered plans, as the protocol does not ex-
plicitly state an order. To allow for a specific ordering of these two
sub-plans we include a manual activation, but assume that the ac-
tivation will be performed by a doctor eventually. In case of BCT,
the axillary staging starts with an investigation of the sentinel nodes
provided that there are no contra indications for doing this. In case
it is rejected or, because the sentinel nodes are positive, the plan is
aborted, and an axillary dissection has to be performed. Furthermore,
it is possible that the excision aborts because the margins are not tu-
mour free. Since BCT surgery waits for this sub-plan, in that case
BCT surgery has to be aborted and therefore it is mandatory to do a
MRM. Finally, we model that the MRM consists of a dissection of
the axilla and a mastectomy as defined by the protocol. No particular
order between the two is given.
The formal semantics of the Asbru model in Figure 2 is based
on the plan state model described in [1], of which an SMV model
was constructed using the method and tool described in [2]. Most
variables dealing with patient data are initialised as unknown and re-
ceive an indeterministic value in the second step to make sure there is
only one root of the model. Furthermore, we assume that they do not
change during the treatment. The only variables that are initialised
at a later stage are the status of the sentinel node, which becomes
known during the SNP and whether or not the tumour margins that
have been resected are tumour free, which becomes known at the
excision of the tumour. Furthermore, fairness constraints have been
added to ensure that the manual activation of both the axilla surgery
and the tumour excision eventually occurs. In other words, the patient
will not wait indefinitely for the treatments to start.
Using the above formalisation, the IKO protocol can be verified
using the constraints of the CBO guideline using standard model
checking techniques. However, guidelines and protocols are usually
under-constrained, thereby allowing many treatment paths not occur-
ing in medical practice. We therefore look at the inclusion of medical
management in practice in the following section.
5 Comparison Using Background Knowledge
In this section, we use the textbook of Roses [15] to create a precise
model of medical management in practice. This model will be for-
malized into a decision tree, referred to as background knowledge,
which will be used to select that part of the IKO protocol that is con-
sistent with [15] and then verify for only this selected part whether










abort: margins not tumour free
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filter: no contra−indications for BCT
wait for SN or dissection−of−axilla
filter: no contraindications for SN
wait for axillary staging and tumour excision
wait for BCT surgery or MRM
Figure 2. Asbru interpretation of IKO protocol. Arrows represent sequential plans, dotted lines represent unordered sub-plans
5.1 Medical Management in Practice
According to [15], the sentinel node procedure (SNP) is started be-
fore segmental excision (i.e., used in BCT) or mastectomy. The sen-
tinel nodes (SNs) are then immediately sent to the pathology lab,
where they are examined during surgery. If the SLNs are found to
be positive, axillary dissection can be completed during the primary
breast surgery in one setting.
Furthermore, [15] differs with the CBO guideline and IKO proto-
col in the case of recurrent tumour positive re-section margins in the
BCT treatment. Whereas CBO and IKO recommend to switch the
treatment to MRM, which includes axillary dissection, [15] only rec-



































Figure 3. Background knowledge: possible treatment paths for surgery of
operable invasive breast cancer. CI-BCT = contra indications BCT, CI-SN =
contra indications SNP, TF = tumour free resection margins, AD = axillary
dissection.
Information from [15] can be represented in a decision tree as
shown in Figure 3, which deals with the ordering of medical actions
treating the primary tumour (BCT and MRM) and the axilla (SN
and/or AD).6 Nodes represent medical actions or plans, arcs repre-
sent constraints. A path from the root node to a leaf node represents
a treatment path, which defines the order of medical actions when the
constraints on the path are satisfied.
5.2 Comparing Medical Management with the
IKO Protocol
Clearly, the medical management stated by the IKO protocol is less
precise than the medical management performed in practice. Typi-
cally, one would expect the medical management in the protocol to
be under constrained when compared to the medical management in
practice. To verify this for the IKO protocol, we have transformed the
7 possible treatment paths in Figure 3 into a number of CTL prop-
erties (2 shown below) and verified whether these paths occur in the
protocol.
(1) EX(¬CI-BCT ∧ ¬CI-SN ∧
EF(sentinel-node ∧ SN = neg ∧
EF(tumour-excision ∧ TF ∧
AG(¬mastectomy ∧ ¬AD))))
(2) EX(¬CI-BCT ∧ ¬CI-SN ∧
EF(sentinel-node ∧ SN = neg ∧
EF(tumour-excision ∧ ¬TF ∧
EF(mastectomy) ∧ AG(¬AD))))
With the SMV model checker we were able to verify that all paths,
except (2), can occur in the IKO protocol. Path (2) does not hold
in the IKO protocol because it recommends a MRM whereas [15]
recommends a mastectomy, i.e., axillary dissection is included in the
medical management according to the protocol, but not according to
[15]. Whether the protocol or the textbook is incomplete or incorrect
should be discussed with medical experts.
6 We abstract from radiotherapy and isolated tumour cells.
5.3 Selective Comparison of Guideline Constraints
and Protocol
Clearly medical management is much less precisely defined in the
CBO guideline and the IKO protocol than in the medical textbook of
Roses [15]. Hence, any model that is only based on a written docu-
ment of a guideline or protocol without the inclusion of background
knowledge, will include many paths in which medical actions are
unrealistically ordered. Many rightful properties of medical manage-
ment may therefore not hold for the model constructed. Either one
can choose to improve the model such that it adheres to medical prac-
tice (but not to the guideline document), or one can select only those
paths in the model that also occur in medical practice for which then
the property needs to be proven.
One approach to accomplish this is by including assertions to the
model of the protocol or guideline. Assertions are statements that
should hold in every execution path of the protocol, which, in Ca-
dence SMV, are written down in the form of linear time logic (LTL)
properties. This makes it possible to state properties about the rela-
tion of medical actions in time. In order to do this, the background
knowledge formalised in terms of a decision tree, needs to be inter-
preted in terms of such LTL assertions. It is obvious to guarantee that
such statements are sound with respect to the decision tree. Here, we
consider the following LTL assertions.
(1) (¬CI-BCT ∧ ¬CI-SN) ↔ F sentinel-node
(2) (F sentinel-node) →
((¬tumour-excision U sentinel-node) ∧
F tumour-excision)
(3) ((F sentinel-node) ∧ SN = neg ∧
(F TF)) → (¬(F AD) ∧ ¬(F MRM))
(4) ((F sentinel-node) ∧ SN = neg ∧ (F ¬TF)) →
((F mastectomy) ∧ ¬F AD)
(5) ((F sentinel-node) ∧ SN = pos ∧ (F TF)) →
((F AD) ∧ ¬(F MRM))
(6) ((F sentinel-node) ∧ SN = pos ∧ (F ¬TF)) → F MRM
(7) (CI-BCT → (¬(F tumour-excision) ∧ F MRM))
(8) (¬CI-BCT ∧ CI-SN) → F tumour-excision
(9) (¬CI-BCT ∧ CI-SN ∧ (F TF)) → ((F AD) ∧ ¬(F MRM))
(10) (¬CI-BCT ∧ CI-SN ∧ (F ¬TF)) → F MRM
Assumption (1) and (2) deals with the use of sentinel node procedure
and the order between this and the excision of the tumour. Assump-
tions (3) to (6) are concerned with paths (1) to (4). Assumption (7)
deals with path (5). Finally assumptions (8) and (9) deals with path
(6) and (7). However, we have seen in the previous section that (4) is
not coherent with the model (i.e., from (4) it follows the antecedent
of (4) is false), so in this form it is not usable. We could therefore
either adapt the assumption so that it corresponds to the guideline or
omit it. Here, we have omitted it.
Verifying the guideline constraints with SMV on the Asbru model
of the IKO protocol using these assumptions, shows that, consistent
with the description in Section 5.2, constraint (9) does not hold in
the Asbru model of the IKO protocol, indicating a difference be-
tween protocol and guideline with respect to medical management
in practice. Although, in this case the difference between protocol
and guideline is clear and could also have more easily been found
through an informal analysis, this is largely because the protocol and
guideline have a very similar structure and their recommendations
are almost identical. However, the approach taken is independent of
the underlying structure of the protocol and guideline. Therefore,
this case study shows that formal techniques can be used to com-
pare guideline and protocol independent of their underlying docu-
ment structure.
6 Related Work
Researchers in AI acknowledge that medical guidelines are good
real-world examples of highly structured documents that are
amenable for formalization. Much research has already focused on
designing computer-oriented languages and developing tools for
their employment. However, not many researchers seem to note that
guidelines may exist at different levels of abstraction, which we des-
ignated here as ‘guideline’ and ‘protocol’ with protocol being a less
abstract version of a guideline. Taking this view on guidelines raises
a nummer of issues currently not addressed in literature.
First, guidelines are typically under-constrained thereby omitting
many details about treatment order. Our work contrasts on this point
with [17] for example, in which guidelines are more viewed as pro-
grams, but in which no execution paths are excluded that are illog-
ical for medical management in practice. Clearly, additional medi-
cal background knowledge is needed to supplement the knowledge
in the guideline document as was already acknowledged in previ-
ous work [11, 10]. Whereas in previous work we incorporated back-
ground knowledge into the model, here we have used background
knowledge to restrain the number of possible execution paths.
Second, researchers have focused on the verification of the quality
of medical guidelines. However, verification of guidelines still takes
a lot of effort. By using formal methods to find differences between
a protocol and a guideline, one could reuse verification results of
the guideline for the protocol and only focus on those parts that are
different. Current work on verification of guidelines only consider
guidelines to be solitary objects. No reference is made to verifying
adaptations of guidelines.
Third, locating differences between guidelines and protocols is a
novel topic, which has previously only been looked at from an in-
formal angle [13]. The formal techniques used in our research ex-
tends previous work on model checking medical guidelines [2] and
complements the techniques used in earlier work on quality checking
medical guidelines [17, 11, 10].
7 Discussion
The aim of this work was to obtain insight into the differences and
similarities between guidelines and protocols, based on the assump-
tion that protocols should be looked upon as local modifications of
guidelines. As a guideline is a starting point for drafting a protocol
concerning the same topic, the development of a protocol based on a
guideline can been seen as a transformation process. In the project,
we have only been able to find end point protocols; as a consequence,
the transformation process could only be described as consisting of
a single step. In reality, it may be a more iterative process to design
a protocol on the basis of an available guideline.
With the help of an expert clinical oncologist, a preliminary infor-
mal analysis of the protocol about management of breast cancer was
carried out, which yielded insights into differences and similarities
that were valuable as a starting point for a more in-depth analysis
using formal methods.
One of the questions that emerged in the course of the research
was whether the guideline or protocol ought to be adopted as the
gold standard for comparison. Based on insights obtained by consult-
ing literature on guideline development, we decided to take neither
the guideline nor the protocol as the gold standard, but medical man-
agement in practice up to the point where it is consistent with the
guideline and/or protocol. Using model-checking as principal tool,
the guideline and protocol, now seen as defining logical constraints
to medical management, were compared to a decision tree describ-
ing the medical management. Some of the outcomes of this research
cast doubts on the content of both guideline and protocol, in the sense
that at least some sort of explanation is needed in order to understand
why there are differences between the decision tree, on the one hand,
and guideline and protocol, on the other hand. We believe that these
results give a promising starting point for further investigating the
relations between guidelines, protocols, and medical management in
practice.
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